首页 > 最新文献

Tropical Diseases, Travel Medicine and Vaccines最新文献

英文 中文
Utilising community volunteers can increase the detection and referral of Buruli ulcer cases in endemic communities in Southeast, Nigeria. 在尼日利亚东南部的布路里溃疡流行社区,利用社区志愿者可以提高布路里溃疡病例的发现率和转诊率。
IF 2.4 Q3 INFECTIOUS DISEASES Pub Date : 2022-11-01 DOI: 10.1186/s40794-022-00181-7
Chihurumnanya Alo, Ijeoma Nkem Okedo-Alex, Ifeyinwa Chizoba Akamike, Adaoha Pearl Agu, Ifeyinwa Maureen Okeke, Chidinma Ihuoma Amuzie, Nneamaka C Alo

Background: Buruli ulcer (BU) is a debilitating neglected tropical disease which causes disability and mostly affects inhabitants in impoverished settings where access to medical care is challenging. This study aims to determine the effect of training community members as volunteers for or in the detection and referral of people who have Buruli ulcer to the hospital.

Methods: The following study is a before and after study in the BU-endemic Local Government Areas (LGA) of Ebonyi State. A cluster random sampling technique was used to select 90 volunteers from three LGAs (30 from each LGA). In each LGA, the volunteers underwent a one-day training and six months field work to identify all those who have any form of ulcer on any part of their bodies. A short questionnaire was used to capture socio-demographic characteristics of the patient, site of the ulcer, duration of the ulcer, initial appearance of the ulcer, referral to hospital, result of laboratory investigation, and treatment received. The data was analysed using the Statistical Package for Social Sciences (SPSS) for Microsoft Windows version 20 software. The Z test statistic was used to compare the number of referred BU patients before and after the intervention by LGA. The Chi square test was used to examine the association between the dependent and independent variables.

Results: The mean age of volunteers was 39 ± 9.5 while mean age of the patients was 42.3 ± 17.1. Most of the ulcers were on the legs (79.4%) and lasted 1-5 years (65.6%). There was a significant increase in the proportion of BU suspects identified by the community volunteers in all 3 LGAs (Afikpo north (p =  < 0.001), Abakaliki (p = 0.02), Ikwo (p = 0.001). The duration of the ulcer was associated with the detection and referral of the patients with higher levels of detection and referral among those whose ulcer had lasted 1-5 years in two of the LGAs (P < 0.001).

Conclusion: We recommend that program managers and stakeholders integrate and scale up the services of trained community health volunteers for the rapid detection of Buruli ulcer cases in rural endemic communities. Awareness and sensitization campaigns on BU preventive measures should be intensified.

背景:布路里溃疡(Buuli ulcer,BU)是一种被忽视的热带疾病,会导致残疾,主要影响贫困地区的居民,他们很难获得医疗服务。本研究旨在确定对社区成员进行培训,使其成为发现布路里溃疡患者并将其转诊到医院的志愿者的效果:以下研究是在埃邦伊州布路里溃疡流行的地方政府区域(LGA)进行的一项前后对比研究。研究采用聚类随机抽样技术,从三个地方政府区(每个地方政府区 30 人)抽取了 90 名志愿者。在每个地方行政区,志愿者都接受了为期一天的培训,并进行了为期六个月的实地工作,以确定所有身体任何部位患有任何形式溃疡的人。志愿者们使用简短的问卷调查来了解患者的社会人口特征、溃疡部位、溃疡持续时间、溃疡初期症状、转院情况、实验室检查结果以及接受治疗的情况。数据使用微软视窗 20 版社会科学统计软件包(SPSS)进行分析。Z 检验统计用于比较各地方行政区干预前后转诊的 BU 患者人数。因变量和自变量之间的关系采用卡方检验:志愿者的平均年龄为(39 ± 9.5)岁,患者的平均年龄为(42.3 ± 17.1)岁。大多数溃疡发生在腿部(79.4%),持续时间为 1-5 年(65.6%)。在所有 3 个地方行政区(阿菲克波北部),社区志愿者发现的溃疡病疑似患者比例均有明显增加(P = 结论:溃疡病疑似患者比例明显增加):我们建议项目管理人员和利益相关者整合并扩大训练有素的社区卫生志愿者的服务范围,以便在布路里溃疡流行的农村社区快速发现布路里溃疡病例。应加强对布路里溃疡预防措施的认识和宣传活动。
{"title":"Utilising community volunteers can increase the detection and referral of Buruli ulcer cases in endemic communities in Southeast, Nigeria.","authors":"Chihurumnanya Alo, Ijeoma Nkem Okedo-Alex, Ifeyinwa Chizoba Akamike, Adaoha Pearl Agu, Ifeyinwa Maureen Okeke, Chidinma Ihuoma Amuzie, Nneamaka C Alo","doi":"10.1186/s40794-022-00181-7","DOIUrl":"10.1186/s40794-022-00181-7","url":null,"abstract":"<p><strong>Background: </strong>Buruli ulcer (BU) is a debilitating neglected tropical disease which causes disability and mostly affects inhabitants in impoverished settings where access to medical care is challenging. This study aims to determine the effect of training community members as volunteers for or in the detection and referral of people who have Buruli ulcer to the hospital.</p><p><strong>Methods: </strong>The following study is a before and after study in the BU-endemic Local Government Areas (LGA) of Ebonyi State. A cluster random sampling technique was used to select 90 volunteers from three LGAs (30 from each LGA). In each LGA, the volunteers underwent a one-day training and six months field work to identify all those who have any form of ulcer on any part of their bodies. A short questionnaire was used to capture socio-demographic characteristics of the patient, site of the ulcer, duration of the ulcer, initial appearance of the ulcer, referral to hospital, result of laboratory investigation, and treatment received. The data was analysed using the Statistical Package for Social Sciences (SPSS) for Microsoft Windows version 20 software. The Z test statistic was used to compare the number of referred BU patients before and after the intervention by LGA. The Chi square test was used to examine the association between the dependent and independent variables.</p><p><strong>Results: </strong>The mean age of volunteers was 39 ± 9.5 while mean age of the patients was 42.3 ± 17.1. Most of the ulcers were on the legs (79.4%) and lasted 1-5 years (65.6%). There was a significant increase in the proportion of BU suspects identified by the community volunteers in all 3 LGAs (Afikpo north (p =  < 0.001), Abakaliki (p = 0.02), Ikwo (p = 0.001). The duration of the ulcer was associated with the detection and referral of the patients with higher levels of detection and referral among those whose ulcer had lasted 1-5 years in two of the LGAs (P < 0.001).</p><p><strong>Conclusion: </strong>We recommend that program managers and stakeholders integrate and scale up the services of trained community health volunteers for the rapid detection of Buruli ulcer cases in rural endemic communities. Awareness and sensitization campaigns on BU preventive measures should be intensified.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":null,"pages":null},"PeriodicalIF":2.4,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623928/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40447265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systemic protothecosis in an immunocompetent patient. 免疫功能正常患者的系统性原鞘病。
IF 3.1 Q2 Medicine Pub Date : 2022-10-15 DOI: 10.1186/s40794-022-00180-8
Alvano Trespalacios Sierra, Bárbara Arroyo-Salgado, Jesús Rodriguez-Blanco, Ingrid Tibocha Gordon, María Cristina Martínez-Ávila

Background: Although uncommon, there is increasing interest and public health concerns of the pathogen Prototheca spp, a ubiquitous achlorophilic microalgae that can affect both humans and animals. High mortality rates have been reported in immunocompromised patients with disseminated infection, but no data is available in the immunocompetent population.

Case presentation: We present the case of a 59-year-old man from rural area of Colombia who was admitted to the intensive care unit due to decompensated heart failure that was difficult to medically manage, with development of septic shock and isolation of Prototheca wickerhamii from blood culture. Fluconazole and Amphotericin B were given with successful outcome.

Conclusions: To date, protothecosis and its virulence factors and pathogenesis remain to be fully understood, in our case the isolation of this microalga and its implication of exacerbating chronic conditions such as heart failure is unclear. The medical-scientific community is invited to study this microorganism to determine effective management strategies, as well as its timely identification, treatment, and control, to avoid fatal outcomes.

背景:虽然不常见,但病原体原藻(Prototheca spp)是一种普遍存在的可影响人类和动物的嗜绿微藻,引起了越来越多的兴趣和公共卫生关注。据报道,免疫功能低下的弥散性感染患者的死亡率很高,但在免疫功能正常的人群中没有数据。病例介绍:我们报告一名来自哥伦比亚农村地区的59岁男子,因失代偿性心力衰竭而入院重症监护室,该心力衰竭难以进行医学治疗,并发感染性休克并从血液培养中分离出维克哈米氏原鞘菌。给予氟康唑和两性霉素B治疗效果良好。结论:迄今为止,原生藻及其毒力因素和发病机制仍未完全了解,在本研究中,这种微藻的分离及其对慢性疾病如心力衰竭的加重意义尚不清楚。医学科学界被邀请研究这种微生物,以确定有效的管理策略,以及及时识别,治疗和控制,以避免致命的后果。
{"title":"Systemic protothecosis in an immunocompetent patient.","authors":"Alvano Trespalacios Sierra,&nbsp;Bárbara Arroyo-Salgado,&nbsp;Jesús Rodriguez-Blanco,&nbsp;Ingrid Tibocha Gordon,&nbsp;María Cristina Martínez-Ávila","doi":"10.1186/s40794-022-00180-8","DOIUrl":"https://doi.org/10.1186/s40794-022-00180-8","url":null,"abstract":"<p><strong>Background: </strong>Although uncommon, there is increasing interest and public health concerns of the pathogen Prototheca spp, a ubiquitous achlorophilic microalgae that can affect both humans and animals. High mortality rates have been reported in immunocompromised patients with disseminated infection, but no data is available in the immunocompetent population.</p><p><strong>Case presentation: </strong>We present the case of a 59-year-old man from rural area of Colombia who was admitted to the intensive care unit due to decompensated heart failure that was difficult to medically manage, with development of septic shock and isolation of Prototheca wickerhamii from blood culture. Fluconazole and Amphotericin B were given with successful outcome.</p><p><strong>Conclusions: </strong>To date, protothecosis and its virulence factors and pathogenesis remain to be fully understood, in our case the isolation of this microalga and its implication of exacerbating chronic conditions such as heart failure is unclear. The medical-scientific community is invited to study this microorganism to determine effective management strategies, as well as its timely identification, treatment, and control, to avoid fatal outcomes.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2022-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569104/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33513511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Colonization with extended-spectrum beta-lactamase-producing Escherichia coli and traveler's diarrhea attack rates among travelers to India: a systematic review and meta-analysis. 印度旅行者中广谱β -内酰胺酶产大肠杆菌的定植和旅行者腹泻发病率:一项系统回顾和荟萃分析。
IF 3.1 Q2 Medicine Pub Date : 2022-10-01 DOI: 10.1186/s40794-022-00179-1
Basilua Andre Muzembo, Kei Kitahara, Ayumu Ohno, Keinosuke Okamoto, Shin-Ichi Miyoshi

Background: India is an attractive destination for travelers. Unfortunately, numerous reports exist on traveler's diarrhea (TD) and fecal colonization with extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) among international travelers visiting India. Here, we systematically reviewed studies published on the acquisition of ESBL-EC and TD attack rates among international visitors to India.

Methods: Design: Systematic review and meta-analysis. A systematic search was performed using Google Scholar, PubMed, EMBASE, Web of Science, and gray literature from 2000 to December 2021, for studies containing data for ESBL-EC acquisition or TD experience related to a trip to India. Random effects models were used to compute the prevalence of ESBL-EC acquisition and TD attack.

Results: The literature search yielded a total of 5023 records. Of these, 31 met our inclusion criteria for systematic review and only 17 could be meta-analyzed (9 for TD, and 8 for ESBL-EC). The overall pooled attack rate of TD was 39% (95% confidence interval, CI: 25-53%). In studies where travelers' memory was used to diagnose TD, the pooled attack rate of TD was slightly higher (42%, 95% CI: 21-64%) compared to those where TD was objectively documented (33%, 95% CI: 17-49%). There were significant risks to be colonized with ESBL-EC among the travelers who experienced TD. The pooled rate of ESBL-EC colonization was 72% (CI: 67-78%). Most ESBL-EC produced CTX-M-15 enzyme. Furthermore, most of the travelers who acquired ESBL-EC were from highly industrialized countries recruited from travel clinics: Canada (n = 80), Germany (n = 69), Netherlands (n = 20), Sweden (n = 18), Japan (n = 10), Finland (n = 8), USA (n = 7), Spain (n = 5), and Denmark (n = 3).

Conclusions: TD pooled attack rate and ESBL-EC acquisition among international travelers visiting India were high in this study. However, we cannot make generalizations based upon this TD pooled attack rate for the current situation, due to a lack of current data. Our study highlights that travelers should be advised on TD to ensure that they do not disregard the risk of contracting TD and be better prepared as a result. It also illustrates the importance of international travel in acquiring antibiotic-resistant Escherichia coli.

背景:印度是一个吸引游客的目的地。不幸的是,在访问印度的国际旅行者中存在大量关于旅行者腹泻(TD)和产生广谱β -内酰胺酶的大肠杆菌(ESBL-EC)粪便定殖的报道。在这里,我们系统地回顾了关于在印度的国际游客中获得ESBL-EC和TD发病率的研究。方法:设计:系统评价和荟萃分析。使用Google Scholar、PubMed、EMBASE、Web of Science和2000年至2021年12月的灰色文献进行系统搜索,寻找包含与印度之旅相关的ESBL-EC获取或TD体验数据的研究。采用随机效应模型计算ESBL-EC获取率和TD攻击率。结果:文献检索共获得5023条记录。其中31例符合我们的系统评价纳入标准,只有17例可以进行meta分析(9例用于TD, 8例用于ESBL-EC)。TD的总总发作率为39%(95%置信区间,CI: 25-53%)。在使用旅行者记忆诊断TD的研究中,与客观记录TD的研究(33%,95% CI: 17-49%)相比,TD的总发作率略高(42%,95% CI: 21-64%)。在经历过TD的旅行者中,有很大的风险被ESBL-EC定植。ESBL-EC的总定殖率为72% (CI: 67-78%)。大多数ESBL-EC产生CTX-M-15酶。此外,大多数获得ESBL-EC的旅行者来自高度工业化国家的旅行诊所:加拿大(n = 80)、德国(n = 69)、荷兰(n = 20)、瑞典(n = 18)、日本(n = 10)、芬兰(n = 8)、美国(n = 7)、西班牙(n = 5)和丹麦(n = 3)。结论:在本研究中,访问印度的国际旅行者的TD合并发病率和ESBL-EC获取率较高。然而,由于缺乏当前数据,我们无法根据当前情况的TD池攻击率进行概括。我们的研究强调,旅行者应该被告知TD,以确保他们不会忽视感染TD的风险,并因此做好更好的准备。它还说明了国际旅行对获得耐抗生素大肠杆菌的重要性。
{"title":"Colonization with extended-spectrum beta-lactamase-producing Escherichia coli and traveler's diarrhea attack rates among travelers to India: a systematic review and meta-analysis.","authors":"Basilua Andre Muzembo,&nbsp;Kei Kitahara,&nbsp;Ayumu Ohno,&nbsp;Keinosuke Okamoto,&nbsp;Shin-Ichi Miyoshi","doi":"10.1186/s40794-022-00179-1","DOIUrl":"https://doi.org/10.1186/s40794-022-00179-1","url":null,"abstract":"<p><strong>Background: </strong>India is an attractive destination for travelers. Unfortunately, numerous reports exist on traveler's diarrhea (TD) and fecal colonization with extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) among international travelers visiting India. Here, we systematically reviewed studies published on the acquisition of ESBL-EC and TD attack rates among international visitors to India.</p><p><strong>Methods: </strong>Design: Systematic review and meta-analysis. A systematic search was performed using Google Scholar, PubMed, EMBASE, Web of Science, and gray literature from 2000 to December 2021, for studies containing data for ESBL-EC acquisition or TD experience related to a trip to India. Random effects models were used to compute the prevalence of ESBL-EC acquisition and TD attack.</p><p><strong>Results: </strong>The literature search yielded a total of 5023 records. Of these, 31 met our inclusion criteria for systematic review and only 17 could be meta-analyzed (9 for TD, and 8 for ESBL-EC). The overall pooled attack rate of TD was 39% (95% confidence interval, CI: 25-53%). In studies where travelers' memory was used to diagnose TD, the pooled attack rate of TD was slightly higher (42%, 95% CI: 21-64%) compared to those where TD was objectively documented (33%, 95% CI: 17-49%). There were significant risks to be colonized with ESBL-EC among the travelers who experienced TD. The pooled rate of ESBL-EC colonization was 72% (CI: 67-78%). Most ESBL-EC produced CTX-M-15 enzyme. Furthermore, most of the travelers who acquired ESBL-EC were from highly industrialized countries recruited from travel clinics: Canada (n = 80), Germany (n = 69), Netherlands (n = 20), Sweden (n = 18), Japan (n = 10), Finland (n = 8), USA (n = 7), Spain (n = 5), and Denmark (n = 3).</p><p><strong>Conclusions: </strong>TD pooled attack rate and ESBL-EC acquisition among international travelers visiting India were high in this study. However, we cannot make generalizations based upon this TD pooled attack rate for the current situation, due to a lack of current data. Our study highlights that travelers should be advised on TD to ensure that they do not disregard the risk of contracting TD and be better prepared as a result. It also illustrates the importance of international travel in acquiring antibiotic-resistant Escherichia coli.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525155/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40387033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Travel related histoplasmosis - a diagnostic challenge in a patient with tumor necrosis factor alpha (TNF-α) inhibitor therapy. 旅行相关组织胞浆菌病-肿瘤坏死因子α (TNF-α)抑制剂治疗患者的诊断挑战
IF 3.1 Q2 Medicine Pub Date : 2022-09-15 DOI: 10.1186/s40794-022-00178-2
Eveline Hofmann, Konrad Mühlethaler, Matthias Pollak, Daniel Ott, Nora Bienz, Stefan Zimmerli, Cédric Hirzel

Introduction: In a non-endemic setting, disseminated histoplasmosis is a rare travel-related health problem of immunosuppressed returnees from endemic regions.

Methods: We describe the case of a 68-year-old man with rheumatoid arthritis and tumor necrosis factor alpha (TNF-α) inhibitor treatment-related immunodeficiency, who suffered from disseminated histoplasmosis after traveling to Brazil. Based on this case, we discuss challenges and pitfalls associated with the diagnosis of disseminated histoplasmosis in a non-endemic setting.

Results: The disease mimicked a hemophagocytic lymphohistiocytosis (HLH) like syndrome. Histoplasma capsulatum was microscopically detected in bronchoalveolar fluid and bone marrow aspirate smears, but was initially misclassified as Leishmania spp., another class of pathogens, which may cause HLH like syndromes in immunocompromised individuals.

Discussion: Since the clinical symptoms of histoplasmosis are nonspecific and physicians in non-endemic regions might not be familiar with this disease pattern, there is a risk of delayed diagnosis of travel related cases. Taking a thorough travel history is key in unclear cases of illness in immunocompromised patients.

在非地方性环境中,播散性组织胞浆菌病是一种罕见的与旅行相关的健康问题,发生在来自地方性地区的免疫抑制返回者中。方法:我们描述了一例68岁的类风湿关节炎和肿瘤坏死因子α (TNF-α)抑制剂治疗相关免疫缺陷的男性,他在去巴西旅行后患上了弥散性组织胞浆菌病。基于这个病例,我们讨论了在非地方性环境中与播散性组织胞浆菌病诊断相关的挑战和陷阱。结果:本病表现为嗜血球淋巴组织细胞增多症(HLH)样综合征。显微镜下在支气管肺泡液和骨髓抽吸涂片中检测到荚膜组织浆体,但最初被错误地归类为利什曼原虫,这是另一类病原体,可能在免疫功能低下的个体中引起HLH样综合征。讨论:由于组织浆菌病的临床症状是非特异性的,非流行地区的医生可能不熟悉这种疾病模式,因此存在旅行相关病例延误诊断的风险。在免疫功能低下患者的不明病例中,全面了解旅行史是关键。
{"title":"Travel related histoplasmosis - a diagnostic challenge in a patient with tumor necrosis factor alpha (TNF-α) inhibitor therapy.","authors":"Eveline Hofmann,&nbsp;Konrad Mühlethaler,&nbsp;Matthias Pollak,&nbsp;Daniel Ott,&nbsp;Nora Bienz,&nbsp;Stefan Zimmerli,&nbsp;Cédric Hirzel","doi":"10.1186/s40794-022-00178-2","DOIUrl":"https://doi.org/10.1186/s40794-022-00178-2","url":null,"abstract":"<p><strong>Introduction: </strong>In a non-endemic setting, disseminated histoplasmosis is a rare travel-related health problem of immunosuppressed returnees from endemic regions.</p><p><strong>Methods: </strong>We describe the case of a 68-year-old man with rheumatoid arthritis and tumor necrosis factor alpha (TNF-α) inhibitor treatment-related immunodeficiency, who suffered from disseminated histoplasmosis after traveling to Brazil. Based on this case, we discuss challenges and pitfalls associated with the diagnosis of disseminated histoplasmosis in a non-endemic setting.</p><p><strong>Results: </strong>The disease mimicked a hemophagocytic lymphohistiocytosis (HLH) like syndrome. Histoplasma capsulatum was microscopically detected in bronchoalveolar fluid and bone marrow aspirate smears, but was initially misclassified as Leishmania spp., another class of pathogens, which may cause HLH like syndromes in immunocompromised individuals.</p><p><strong>Discussion: </strong>Since the clinical symptoms of histoplasmosis are nonspecific and physicians in non-endemic regions might not be familiar with this disease pattern, there is a risk of delayed diagnosis of travel related cases. Taking a thorough travel history is key in unclear cases of illness in immunocompromised patients.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2022-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476690/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40358765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Estimating social contacts in mass gatherings for disease outbreak prevention and management: case of Hajj pilgrimage. 基于疫情防控的人群接触评估——以朝觐为例。
IF 3.1 Q2 Medicine Pub Date : 2022-09-01 DOI: 10.1186/s40794-022-00177-3
Mohammadali Tofighi, Ali Asgary, Ghassem Tofighi, Mahdi M Najafabadi, Julien Arino, Amine Amiche, Ashrafur Rahman, Zachary McCarthy, Nicola Luigi Bragazzi, Edward Thommes, Laurent Coudeville, Martin David Grunnill, Lydia Bourouiba, Jianhong Wu

Background: Most mass gathering events have been suspended due to the SARS-CoV-2 pandemic. However, with vaccination rollout, whether and how to organize some of these mass gathering events arises as part of the pandemic recovery discussions, and this calls for decision support tools. The Hajj, one of the world's largest religious gatherings, was substantively scaled down in 2020 and 2021 and it is still unclear how it will take place in 2022 and subsequent years. Simulating disease transmission dynamics during the Hajj season under different conditions can provide some insights for better decision-making. Most disease risk assessment models require data on the number and nature of possible close contacts between individuals.

Methods: We sought to use integrated agent-based modeling and discrete events simulation techniques to capture risky contacts among the pilgrims and assess different scenarios in one of the Hajj major sites, namely Masjid-Al-Haram.

Results: The simulation results showed that a plethora of risky contacts may occur during the rituals. Also, as the total number of pilgrims increases at each site, the number of risky contacts increases, and physical distancing measures may be challenging to maintain beyond a certain number of pilgrims in the site.

Conclusions: This study presented a simulation tool that can be relevant for the risk assessment of a variety of (respiratory) infectious diseases, in addition to COVID-19 in the Hajj season. This tool can be expanded to include other contributing elements of disease transmission to quantify the risk of the mass gathering events.

背景:受新冠肺炎疫情影响,大部分群众聚集活动暂停。然而,随着疫苗接种的推出,是否以及如何组织这些大规模聚集活动成为大流行恢复讨论的一部分,这就需要决策支持工具。作为世界上最大的宗教集会之一,朝觐在2020年和2021年大幅缩减,2022年及随后几年的情况仍不明朗。模拟朝觐季节不同条件下的疾病传播动态可以为更好的决策提供一些见解。大多数疾病风险评估模型都需要关于个人之间可能密切接触者的数量和性质的数据。方法:我们试图使用集成的基于智能体的建模和离散事件模拟技术来捕捉朝圣者之间的危险接触,并评估朝觐主要地点之一(即清真寺-哈拉姆)的不同情景。结果:模拟结果表明,在仪式期间可能会发生过多的风险接触。此外,随着每个地点朝圣者总数的增加,危险接触的数量也会增加,在该地点超过一定数量的朝圣者后,保持物理距离的措施可能具有挑战性。结论:本研究提出了一种模拟工具,可用于朝觐季节除COVID-19外的各种(呼吸道)传染病的风险评估。这一工具可以扩大到包括疾病传播的其他促成因素,以量化大规模聚集事件的风险。
{"title":"Estimating social contacts in mass gatherings for disease outbreak prevention and management: case of Hajj pilgrimage.","authors":"Mohammadali Tofighi,&nbsp;Ali Asgary,&nbsp;Ghassem Tofighi,&nbsp;Mahdi M Najafabadi,&nbsp;Julien Arino,&nbsp;Amine Amiche,&nbsp;Ashrafur Rahman,&nbsp;Zachary McCarthy,&nbsp;Nicola Luigi Bragazzi,&nbsp;Edward Thommes,&nbsp;Laurent Coudeville,&nbsp;Martin David Grunnill,&nbsp;Lydia Bourouiba,&nbsp;Jianhong Wu","doi":"10.1186/s40794-022-00177-3","DOIUrl":"https://doi.org/10.1186/s40794-022-00177-3","url":null,"abstract":"<p><strong>Background: </strong>Most mass gathering events have been suspended due to the SARS-CoV-2 pandemic. However, with vaccination rollout, whether and how to organize some of these mass gathering events arises as part of the pandemic recovery discussions, and this calls for decision support tools. The Hajj, one of the world's largest religious gatherings, was substantively scaled down in 2020 and 2021 and it is still unclear how it will take place in 2022 and subsequent years. Simulating disease transmission dynamics during the Hajj season under different conditions can provide some insights for better decision-making. Most disease risk assessment models require data on the number and nature of possible close contacts between individuals.</p><p><strong>Methods: </strong>We sought to use integrated agent-based modeling and discrete events simulation techniques to capture risky contacts among the pilgrims and assess different scenarios in one of the Hajj major sites, namely Masjid-Al-Haram.</p><p><strong>Results: </strong>The simulation results showed that a plethora of risky contacts may occur during the rituals. Also, as the total number of pilgrims increases at each site, the number of risky contacts increases, and physical distancing measures may be challenging to maintain beyond a certain number of pilgrims in the site.</p><p><strong>Conclusions: </strong>This study presented a simulation tool that can be relevant for the risk assessment of a variety of (respiratory) infectious diseases, in addition to COVID-19 in the Hajj season. This tool can be expanded to include other contributing elements of disease transmission to quantify the risk of the mass gathering events.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433139/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40334117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vaccines platforms and COVID-19: what you need to know. 疫苗平台和COVID-19:你需要知道的
IF 3.1 Q2 Medicine Pub Date : 2022-08-15 DOI: 10.1186/s40794-022-00176-4
Isabel Acosta-Coley, Leonor Cervantes-Ceballos, Lesly Tejeda-Benítez, Lucellys Sierra-Márquez, María Cabarcas-Montalvo, María García-Espiñeira, Wilfrido Coronell-Rodríguez, Bárbara Arroyo-Salgado

Background: The novel SARS-CoV-2, responsible for the COVID-19 pandemic, is the third zoonotic coronavirus since the beginning of the 21 first century, and it has taken more than 6 million human lives because of the lack of immunity causing global economic losses. Consequently, developing a vaccine against the virus represents the fastest way to finish the threat and regain some "normality."

Objective: Here, we provide information about the main features of the most important vaccine platforms, some of them already approved, to clear common doubts fostered by widespread misinformation and to reassure the public of the safety of the vaccination process and the different alternatives presented.

Methods: Articles published in open access databases until January 2022 were identified using the search terms "SARS-CoV-2," "COVID-19," "Coronavirus," "COVID-19 Vaccines," "Pandemic," COVID-19, and LMICs or their combinations.

Discussion: Traditional first-generation vaccine platforms, such as whole virus vaccines (live attenuated and inactivated virus vaccines), as well as second-generation vaccines, like protein-based vaccines (subunit and viral vector vaccines), and third-generation vaccines, such as nanoparticle and genetic vaccines (mRNA vaccines), are described.

Conclusions: SARS-CoV-2 sequence information obtained in a record time provided the basis for the fast development of a COVID-19 vaccine. The adaptability characteristic of the new generation of vaccines is changing our capability to react to emerging threats to future pandemics. Nevertheless, the slow and unfair distribution of vaccines to low- and middle-income countries and the spread of misinformation are a menace to global health since the unvaccinated will increase the chances for resurgences and the surge of new variants that can escape the current vaccines.

背景:导致COVID-19大流行的新型SARS-CoV-2是21世纪初以来的第三种人畜共患冠状病毒,由于缺乏免疫力,已夺去600多万人的生命,造成全球经济损失。因此,开发一种针对病毒的疫苗是消除威胁并恢复一些“正常”的最快方法。“目的:在此,我们提供有关最重要疫苗平台的主要特征的信息,其中一些已经获得批准,以消除普遍存在的错误信息所造成的普遍疑虑,并使公众对疫苗接种过程的安全性以及所提供的不同替代方案放心。方法:使用检索词“SARS-CoV-2”、“COVID-19”、“冠状病毒”、“COVID-19疫苗”、“大流行”、“COVID-19”和中低收入国家或其组合对开放获取数据库中截至2022年1月发表的文章进行检索。讨论:介绍了传统的第一代疫苗平台,如全病毒疫苗(减毒活疫苗和灭活疫苗),第二代疫苗,如基于蛋白质的疫苗(亚单位和病毒载体疫苗),以及第三代疫苗,如纳米颗粒和遗传疫苗(mRNA疫苗)。结论:在创记录的时间内获得SARS-CoV-2序列信息,为快速研制新型冠状病毒疫苗提供了依据。新一代疫苗的适应性特点正在改变我们应对未来流行病新出现的威胁的能力。然而,向低收入和中等收入国家缓慢和不公平地分发疫苗以及错误信息的传播对全球健康构成威胁,因为未接种疫苗的人将增加疾病复发的机会,并增加可以逃避现有疫苗的新变种的激增。
{"title":"Vaccines platforms and COVID-19: what you need to know.","authors":"Isabel Acosta-Coley,&nbsp;Leonor Cervantes-Ceballos,&nbsp;Lesly Tejeda-Benítez,&nbsp;Lucellys Sierra-Márquez,&nbsp;María Cabarcas-Montalvo,&nbsp;María García-Espiñeira,&nbsp;Wilfrido Coronell-Rodríguez,&nbsp;Bárbara Arroyo-Salgado","doi":"10.1186/s40794-022-00176-4","DOIUrl":"https://doi.org/10.1186/s40794-022-00176-4","url":null,"abstract":"<p><strong>Background: </strong>The novel SARS-CoV-2, responsible for the COVID-19 pandemic, is the third zoonotic coronavirus since the beginning of the 21 first century, and it has taken more than 6 million human lives because of the lack of immunity causing global economic losses. Consequently, developing a vaccine against the virus represents the fastest way to finish the threat and regain some \"normality.\"</p><p><strong>Objective: </strong>Here, we provide information about the main features of the most important vaccine platforms, some of them already approved, to clear common doubts fostered by widespread misinformation and to reassure the public of the safety of the vaccination process and the different alternatives presented.</p><p><strong>Methods: </strong>Articles published in open access databases until January 2022 were identified using the search terms \"SARS-CoV-2,\" \"COVID-19,\" \"Coronavirus,\" \"COVID-19 Vaccines,\" \"Pandemic,\" COVID-19, and LMICs or their combinations.</p><p><strong>Discussion: </strong>Traditional first-generation vaccine platforms, such as whole virus vaccines (live attenuated and inactivated virus vaccines), as well as second-generation vaccines, like protein-based vaccines (subunit and viral vector vaccines), and third-generation vaccines, such as nanoparticle and genetic vaccines (mRNA vaccines), are described.</p><p><strong>Conclusions: </strong>SARS-CoV-2 sequence information obtained in a record time provided the basis for the fast development of a COVID-19 vaccine. The adaptability characteristic of the new generation of vaccines is changing our capability to react to emerging threats to future pandemics. Nevertheless, the slow and unfair distribution of vaccines to low- and middle-income countries and the spread of misinformation are a menace to global health since the unvaccinated will increase the chances for resurgences and the surge of new variants that can escape the current vaccines.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2022-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537331/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40707736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 19
Misdiagnosis and inappropriate treatment of cutaneous leishmaniasis: a case report. 皮肤利什曼病误诊与治疗不当1例报告。
IF 3.1 Q2 Medicine Pub Date : 2022-08-01 DOI: 10.1186/s40794-022-00175-5
Katarzyna Sikorska, Marta Gesing, Romuald Olszański, Anna Roszko-Wysokińska, Beata Szostakowska, Katarzyna Van Damme-Ostapowicz

Background: Leishmaniasis is a widespread disease in tropical and subtropical countries, except for Australia and Oceania. In Poland, tourists, migrants and travellers from leishmaniasis-endemic countries may carry Leishmania.

Case presentation: We present a case of undiagnosed cutaneous leishmaniasis in a patient who received many weeks of inadequate antibiotic treatment. Ulceration in the right submandibular region was thought to be a purulent complication after laser surgery. Six weeks before the ulcer developed, the patient had visited the jungle (Guatemala). Cutaneous leishmaniasis was finally diagnosed after nine months based on a proper history and a polymerase chain reaction (PCR) assay. Treatment with antimony derivatives was administered. After three months, the ulcer healed but left a scar.

Conclusion: A lack of knowledge about tropical diseases among doctors and an incomplete medical history were the reasons for many weeks of erroneous treatment of cutaneous leishmaniasis with antibiotics. This is the first reported case of cutaneous leishmaniasis misdiagnosed as a complication after an aesthetic medical procedure.

背景:利什曼病是除澳大利亚和大洋洲外热带和亚热带国家的一种广泛流行的疾病。在波兰,来自利什曼病流行国家的游客、移民和旅行者可能携带利什曼病。病例介绍:我们提出了一例未确诊的皮肤利什曼病患者谁接受了许多周的抗生素治疗不足。右下颌骨区域溃疡被认为是激光手术后的化脓性并发症。溃疡发生前6周,患者曾去过丛林(危地马拉)。9个月后,根据适当的病史和聚合酶链反应(PCR)测定,最终诊断为皮肤利什曼病。给予锑衍生物治疗。三个月后,溃疡愈合了,但留下了疤痕。结论:医生对热带病知识的缺乏和病史的不完整是导致皮肤利什曼病抗生素治疗错误数周的原因。这是首例报道的皮肤利什曼病误诊为并发症后的美容医疗程序。
{"title":"Misdiagnosis and inappropriate treatment of cutaneous leishmaniasis: a case report.","authors":"Katarzyna Sikorska,&nbsp;Marta Gesing,&nbsp;Romuald Olszański,&nbsp;Anna Roszko-Wysokińska,&nbsp;Beata Szostakowska,&nbsp;Katarzyna Van Damme-Ostapowicz","doi":"10.1186/s40794-022-00175-5","DOIUrl":"https://doi.org/10.1186/s40794-022-00175-5","url":null,"abstract":"<p><strong>Background: </strong>Leishmaniasis is a widespread disease in tropical and subtropical countries, except for Australia and Oceania. In Poland, tourists, migrants and travellers from leishmaniasis-endemic countries may carry Leishmania.</p><p><strong>Case presentation: </strong>We present a case of undiagnosed cutaneous leishmaniasis in a patient who received many weeks of inadequate antibiotic treatment. Ulceration in the right submandibular region was thought to be a purulent complication after laser surgery. Six weeks before the ulcer developed, the patient had visited the jungle (Guatemala). Cutaneous leishmaniasis was finally diagnosed after nine months based on a proper history and a polymerase chain reaction (PCR) assay. Treatment with antimony derivatives was administered. After three months, the ulcer healed but left a scar.</p><p><strong>Conclusion: </strong>A lack of knowledge about tropical diseases among doctors and an incomplete medical history were the reasons for many weeks of erroneous treatment of cutaneous leishmaniasis with antibiotics. This is the first reported case of cutaneous leishmaniasis misdiagnosed as a complication after an aesthetic medical procedure.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341103/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9181951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Cross-platform mobile app development for disseminating public health information to travelers in Thailand: development and usability. 向泰国旅行者传播公共卫生信息的跨平台移动应用程序开发:开发和可用性。
IF 3.1 Q2 Medicine Pub Date : 2022-07-15 DOI: 10.1186/s40794-022-00174-6
Pongthep Meankaew, Saranath Lawpoolsri, Watcharapong Piyaphanee, Peerawat Wansatid, Pimwadee Chaovalit, Siam Lawawirojwong, Jaranit Kaewkungwal

Background: The risk of disease is a key factor that travelers have identified when planning to travel abroad, as many people are concerned about getting sick. Mobile devices can be an effective means for travelers to access information regarding disease prevalence in their planned destinations, potentially reducing the risk of exposure.

Methods: We developed a mobile app, ThaiEpidemics, using cross-platform technology to provide information about disease prevalence and status for travelers to Thailand. We aimed to assess the app's usability in terms of engagement, search logs, and effectiveness among target users. The app was developed using the principle of mobile application development life cycle, for both iOS and Android. As its data source, the app used weekly data from national disease-surveillance reports. We conduced our study among visitors to the Travel Clinic in the Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. The participants were informed that the app would collect usage and search logs related to their queries. After the second log-in, the app prompted participants to complete an e-survey regarding their opinions and preferences related to their awareness of disease prevalence and status.

Results: We based our prototype of ThaiEpidemics on a conceptualized framework for visualizing the distribution of 14 major diseases of concern to tourists in Southeast Asia. The app provided users with functions and features to search for and visualize disease prevalence and status in Thailand. The participants could access information for their current location and elsewhere in the country. In all, 83 people installed the app, and 52 responded to the e-survey. Regardless of age, education, and continent of origin, almost all e-survey respondents believed the app had raised their awareness of disease prevalence and status when travelling. Most participants searched for information for all 14 diseases; some searched for information specifically about dengue and malaria.

Conclusions: ThaiEpidemics is evidently potentially useful for travelers. Should the app be adopted for use by travelers to Thailand, it could have an impact on wider knowledge distribution, which might result in decreased exposure, increased prophylaxis, and therefore a potential decreased burden on the healthcare system. For app developers who are developing/implementing this kind of app, it is important to address standardization of the data source and users' concerns about the confidentiality and safety of their mobile devices.

背景:疾病风险是旅行者在计划出国旅行时确定的一个关键因素,因为许多人担心生病。移动设备可以成为旅行者获取其计划目的地的疾病流行情况信息的有效手段,从而潜在地降低接触风险。方法:我们利用跨平台技术开发了一款名为ThaiEpidemics的移动应用程序,为前往泰国的旅行者提供疾病流行和状况信息。我们的目标是根据用户粘性、搜索记录和目标用户的有效性来评估应用的可用性。该应用程序是根据移动应用程序开发生命周期的原则开发的,适用于iOS和Android。作为数据来源,该应用程序使用了来自国家疾病监测报告的每周数据。我们在泰国曼谷玛希隆大学热带医学院热带病医院旅行诊所的游客中进行了研究。参与者被告知,该应用程序将收集与他们的查询相关的使用和搜索日志。在第二次登录后,该应用程序提示参与者完成一项电子调查,调查内容涉及他们对疾病流行和状况的认识的意见和偏好。结果:我们将泰国流行病的原型建立在概念化框架的基础上,以可视化东南亚游客关注的14种主要疾病的分布。该应用程序为用户提供了搜索和可视化泰国疾病流行和状况的功能和特性。与会者可以获取他们当前位置和该国其他地方的信息。总共有83人安装了这款应用,52人回应了电子调查。无论年龄、教育程度和来自哪个大洲,几乎所有的电子调查受访者都认为,这款应用提高了他们在旅行时对疾病流行和状况的认识。大多数参与者搜索了所有14种疾病的信息;一些人专门搜索关于登革热和疟疾的信息。结论:泰国流行病显然对旅行者有潜在的帮助。如果该应用程序被前往泰国的旅行者采用,它可能会对更广泛的知识传播产生影响,这可能会减少接触,增加预防,从而可能减轻医疗保健系统的负担。对于开发/实现这类应用的应用开发者来说,解决数据源的标准化和用户对其移动设备的保密性和安全性的担忧是很重要的。
{"title":"Cross-platform mobile app development for disseminating public health information to travelers in Thailand: development and usability.","authors":"Pongthep Meankaew,&nbsp;Saranath Lawpoolsri,&nbsp;Watcharapong Piyaphanee,&nbsp;Peerawat Wansatid,&nbsp;Pimwadee Chaovalit,&nbsp;Siam Lawawirojwong,&nbsp;Jaranit Kaewkungwal","doi":"10.1186/s40794-022-00174-6","DOIUrl":"https://doi.org/10.1186/s40794-022-00174-6","url":null,"abstract":"<p><strong>Background: </strong>The risk of disease is a key factor that travelers have identified when planning to travel abroad, as many people are concerned about getting sick. Mobile devices can be an effective means for travelers to access information regarding disease prevalence in their planned destinations, potentially reducing the risk of exposure.</p><p><strong>Methods: </strong>We developed a mobile app, ThaiEpidemics, using cross-platform technology to provide information about disease prevalence and status for travelers to Thailand. We aimed to assess the app's usability in terms of engagement, search logs, and effectiveness among target users. The app was developed using the principle of mobile application development life cycle, for both iOS and Android. As its data source, the app used weekly data from national disease-surveillance reports. We conduced our study among visitors to the Travel Clinic in the Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand. The participants were informed that the app would collect usage and search logs related to their queries. After the second log-in, the app prompted participants to complete an e-survey regarding their opinions and preferences related to their awareness of disease prevalence and status.</p><p><strong>Results: </strong>We based our prototype of ThaiEpidemics on a conceptualized framework for visualizing the distribution of 14 major diseases of concern to tourists in Southeast Asia. The app provided users with functions and features to search for and visualize disease prevalence and status in Thailand. The participants could access information for their current location and elsewhere in the country. In all, 83 people installed the app, and 52 responded to the e-survey. Regardless of age, education, and continent of origin, almost all e-survey respondents believed the app had raised their awareness of disease prevalence and status when travelling. Most participants searched for information for all 14 diseases; some searched for information specifically about dengue and malaria.</p><p><strong>Conclusions: </strong>ThaiEpidemics is evidently potentially useful for travelers. Should the app be adopted for use by travelers to Thailand, it could have an impact on wider knowledge distribution, which might result in decreased exposure, increased prophylaxis, and therefore a potential decreased burden on the healthcare system. For app developers who are developing/implementing this kind of app, it is important to address standardization of the data source and users' concerns about the confidentiality and safety of their mobile devices.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2022-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282896/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40523113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Imported cases of cutaneous leishmaniasis in Cuba, 2017: role of human movement. 2017年古巴输入性皮肤利什曼病病例:人体运动的作用
IF 3.1 Q2 Medicine Pub Date : 2022-07-01 DOI: 10.1186/s40794-022-00171-9
Lianet Monzote, Daniel González, Orestes Blanco, Jorge Fraga, Virginia Capó, Alberto Herrera, Ana Margarita Montalvo

Background: Leishmaniasis is a vector-borne disease caused by several species from genus Leishmania. An increase in the number of cases related to human movement has been informed in the last years. Due to the increase of suspicious leishmaniasis cases arriving in Cuba during 2017, a general analysis is presented herein.

Methods: Clinical samples were collected from 5 patients suspicious of leishmaniasis, received from January to December 2017 at the Institute of Tropical Medicine Pedro Kourí, Cuba. Skin lesion samples were analyzed using different diagnostic assays: direct smear, histological examination, and molecular analysis for species identification. Epidemiological and demographic data were requested from each case and analyzed. Treatment and follow up of patient was also performed.

Results: Five cases were confirmed as Leishmania infection according to microscopic observation and molecular methods results. PCR-18S, PCR-N/RFLP and PCR-F/RFLP identified the following species: L. panamensis (2 cases), L. braziliensis (1 case), L.panamensis/L.guyanensis (1 case), L. mexicana complex (1 case). In treated patients, drugs were well tolerated, cure were documented and no relapse have been currently reported (3 years later).

Conclusions: Clinical characteristics, demographic data, and epidemiological features of infection for each case evidence the potential risk related with travel to endemic areas of leishmaniasis.

Keyworks: Cutaneous leishmaniasis, Epidemiology, Imported cases.

背景:利什曼病是一种由利什曼属几种物种引起的媒介传播疾病。据了解,在过去几年中,与人员流动有关的病例数量有所增加。由于2017年抵达古巴的可疑利什曼病例有所增加,本文提出了总体分析。方法:收集2017年1 - 12月古巴佩德罗Kourí热带医学研究所收治的5例疑似利什曼病患者的临床样本。使用不同的诊断方法对皮肤病变样本进行分析:直接涂片、组织学检查和分子分析以鉴定物种。从每个病例中索取流行病学和人口统计资料并进行分析。并对患者进行了治疗和随访。结果:经显微镜观察和分子检测结果证实5例为利什曼原虫感染。PCR-18S、PCR-N/RFLP和PCR-F/RFLP分别鉴定出L.panamensis(2例)、L. braziliensis(1例)、L.panamensis/L.;guyanensis(1例),L. mexicana complex(1例)。在接受治疗的患者中,药物耐受性良好,有治愈记录,目前没有复发的报道(3年后)。结论:每个病例的临床特征、人口统计数据和感染的流行病学特征都证明了前往利什曼病流行地区旅行的潜在风险。关键词:皮肤利什曼病,流行病学,输入病例。
{"title":"Imported cases of cutaneous leishmaniasis in Cuba, 2017: role of human movement.","authors":"Lianet Monzote,&nbsp;Daniel González,&nbsp;Orestes Blanco,&nbsp;Jorge Fraga,&nbsp;Virginia Capó,&nbsp;Alberto Herrera,&nbsp;Ana Margarita Montalvo","doi":"10.1186/s40794-022-00171-9","DOIUrl":"https://doi.org/10.1186/s40794-022-00171-9","url":null,"abstract":"<p><strong>Background: </strong>Leishmaniasis is a vector-borne disease caused by several species from genus Leishmania. An increase in the number of cases related to human movement has been informed in the last years. Due to the increase of suspicious leishmaniasis cases arriving in Cuba during 2017, a general analysis is presented herein.</p><p><strong>Methods: </strong>Clinical samples were collected from 5 patients suspicious of leishmaniasis, received from January to December 2017 at the Institute of Tropical Medicine Pedro Kourí, Cuba. Skin lesion samples were analyzed using different diagnostic assays: direct smear, histological examination, and molecular analysis for species identification. Epidemiological and demographic data were requested from each case and analyzed. Treatment and follow up of patient was also performed.</p><p><strong>Results: </strong>Five cases were confirmed as Leishmania infection according to microscopic observation and molecular methods results. PCR-18S, PCR-N/RFLP and PCR-F/RFLP identified the following species: L. panamensis (2 cases), L. braziliensis (1 case), L.panamensis/L.guyanensis (1 case), L. mexicana complex (1 case). In treated patients, drugs were well tolerated, cure were documented and no relapse have been currently reported (3 years later).</p><p><strong>Conclusions: </strong>Clinical characteristics, demographic data, and epidemiological features of infection for each case evidence the potential risk related with travel to endemic areas of leishmaniasis.</p><p><strong>Keyworks: </strong>Cutaneous leishmaniasis, Epidemiology, Imported cases.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248147/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40461276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Development and validation of a questionnaire to evaluate the knowledge, attitude and practices regarding travel medicine amongst physicians in an apex tertiary hospital in Northern India. 制定和验证一份调查问卷,以评估印度北部一家顶级三级医院医生关于旅行医学的知识、态度和做法
IF 3.1 Q2 Medicine Pub Date : 2022-06-01 DOI: 10.1186/s40794-022-00170-w
Arvind Kumar, Anand Rajendran, Mohd Usman, Jatin Ahuja, Sameer Samad, Ankit Mittal, Prerna Garg, Upendra Baitha, Piyush Ranjan, Naveet Wig

Objectives: Travel medicine focuses primarily on pre-travel preventive care and the conditions and diseases acquired during or after travel. There is a paucity of validated tools to assess the knowledge, attitude and practises of physicians with regard to travel medicine. We attempted to develop a tool to assess existing expertise among Medicine and Infectious Diseases resident doctors with respect to travel medicine.

Methods: Item level content validity index (I-CVI) and scale level content validity index (S-CVI/Ave) were estimated for each of the items to establish the content validity. Refined measures of inter-rater agreement (Brennan and Prediger Agreement Coefficient and Gwet's Agreement Coefficient) were estimated for the tool.

Results: The final version of the questionnaire had satisfactory content validity (I-CVI > 0∙6 and S-CVI/Ave > 0∙9) and possessed high agreement among the raters (Brennan and Prediger AC > 0∙7, p < 0∙01 and Gwet's AC > 0∙8, p < 0∙01) with regard to necessity, clarity and relevance of the scale.

Conclusions: This tool covers a wide range of questions and is scientifically validated. The final version of the tool can be used largely for the assessment of knowledge, attitude and practices among medical practitioners. This is instrumental to build targeted intervention programs to enhance the knowledge regarding travel medicine among health care providers.

目的:旅行医学主要关注旅行前的预防性护理以及旅行期间或旅行后的疾病。缺乏有效的工具来评估医生在旅行医学方面的知识、态度和实践。我们试图开发一种工具来评估医学和传染病住院医生在旅行医学方面的现有专业知识。方法:评估每个项目的项目级内容有效性指数(I-CVI)和量表级内容有效度指数(S-CVI/Ave),以建立内容有效性。评估了该工具的评分者间一致性的精细度量(Brennan和Prediger一致系数和Gwet一致系数)。结果:问卷的最终版本具有令人满意的内容有效性(I-CVI > 0∙6和S-CVI/Ave > 0∙9),并在评分者中达成高度一致(Brennan和Prediger AC > 0∙7,p  0∙8,p 结论:该工具涵盖了广泛的问题,并经过了科学验证。该工具的最终版本可主要用于评估医生的知识、态度和实践。这有助于建立有针对性的干预计划,以提高医疗保健提供者对旅行医学的了解。
{"title":"Development and validation of a questionnaire to evaluate the knowledge, attitude and practices regarding travel medicine amongst physicians in an apex tertiary hospital in Northern India.","authors":"Arvind Kumar,&nbsp;Anand Rajendran,&nbsp;Mohd Usman,&nbsp;Jatin Ahuja,&nbsp;Sameer Samad,&nbsp;Ankit Mittal,&nbsp;Prerna Garg,&nbsp;Upendra Baitha,&nbsp;Piyush Ranjan,&nbsp;Naveet Wig","doi":"10.1186/s40794-022-00170-w","DOIUrl":"10.1186/s40794-022-00170-w","url":null,"abstract":"<p><strong>Objectives: </strong>Travel medicine focuses primarily on pre-travel preventive care and the conditions and diseases acquired during or after travel. There is a paucity of validated tools to assess the knowledge, attitude and practises of physicians with regard to travel medicine. We attempted to develop a tool to assess existing expertise among Medicine and Infectious Diseases resident doctors with respect to travel medicine.</p><p><strong>Methods: </strong>Item level content validity index (I-CVI) and scale level content validity index (S-CVI/Ave) were estimated for each of the items to establish the content validity. Refined measures of inter-rater agreement (Brennan and Prediger Agreement Coefficient and Gwet's Agreement Coefficient) were estimated for the tool.</p><p><strong>Results: </strong>The final version of the questionnaire had satisfactory content validity (I-CVI > 0∙6 and S-CVI/Ave > 0∙9) and possessed high agreement among the raters (Brennan and Prediger AC > 0∙7, p < 0∙01 and Gwet's AC > 0∙8, p < 0∙01) with regard to necessity, clarity and relevance of the scale.</p><p><strong>Conclusions: </strong>This tool covers a wide range of questions and is scientifically validated. The final version of the tool can be used largely for the assessment of knowledge, attitude and practices among medical practitioners. This is instrumental to build targeted intervention programs to enhance the knowledge regarding travel medicine among health care providers.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155205/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47022853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Tropical Diseases, Travel Medicine and Vaccines
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1